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Monday, February 4, 2013 269asensory neurons from dorsal root (DRG) and trigeminal (TG) ganglia M chan-
nel activity is increased by the mitochondrial release of reactive oxygen species
(ROS) induced by neuromodulator substance P. Here we identified a new sig-
nalling role for nitric oxide (NO) in TG sensory neurons. We show that in rat
TG neurons, the NO donor, S-Nitroso-N-acetyl-DL-penicillamine (SNAP), in-
hibited M-current by 53512% (n=12). This inhibitory effect was blocked by
scavenging of NO and inhibition of NO synthases increased M-current, sug-
gesting that tonic NO levels inhibit M-current in TG neurons. NO increased re-
lease of calcitonin gene-related peptide (CGRP) from TG neurons (130510%
of control, p%0.05), consistent with an increase in neuronal excitability. Im-
portantly, incubation with the M-channel opener retigabine completely abol-
ished increases in CGRP release. We further investigated the mechanism of
the effects of NO on M channels and identified a site of action of NO to be
the same triplet of cysteines, which is also a site of oxidative modification of
M channels by ROS. We now show that the same triplet of cysteines can be
S-nitrosylated in the presence of SNAP. We show that NO and oxidative mod-
ifications have opposing effects on M-current, suggesting that a tightly con-
trolled local redox and NO environment will exert control over M-channel
activity and thus neuronal excitability. Together our data have identified a dy-
namic redox sensor within neuronal M-channels which mediates reciprocal reg-
ulation of channel activity by S-nitrosylation and oxidative modification. This
sensor may play an important role in controlling neuronal excitability by redox
and NO-related mechanisms.
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The human heart demands a constant energy supply to fulfill its function, hence
the decrease in myocardial ATP production plays a key role in the pathogenesis
and progression of ischemic heart diseases. Ischemia also alters electrophysiol-
ogy of the heart, exemplified by an association between an adverse prognosis
and QT interval prolongation in acute myocardial ischemia. KCNQ1 and
KCNE1 form the IKs potassium channel important in terminating cardiac action
potentials. Congenital mutations that compromise IKs function prolong the du-
ration of the ventricular action potential, causing Long QT (LQT) syndrome,
which is associated with a high risk of sudden death. Here we report that the
IKs channel activity increases with ATP concentration ([ATP]) and the EC50
is close to the physiological [ATP] in cardiac myocytes, which indicates that
[ATP] changes such as in ischemia affect IKs channel function. Consistent
with this observation, an LQT-associated mutation in KCNQ1 alters IKs func-
tion by reducing ATP sensitivity. The effect of this mutation is eliminated by
increasing [ATP]. We find that GTP and a non-hydrolyzable ATP analog
AMP-PNP can substitute for ATP in activating the channel, and an ATP analog
can be photo-cross-linked to KCNQ1 proteins expressed in the membrane of
Xenopus oocytes, indicating that the nucleotide directly binds to KCNQ1 to
modify channel function. Compared to ATP, ADP and AMP are less effective
in activating the IKs channel, suggesting that phosphate groups are important in
nucleotide binding. Correspondingly, a mutational scan of all cytosolic basic
residues shows that the ATP binding site may reside in the cytosolic C-termi-
nal. These results demonstrate that IKs is a bona fide ATP activated potassium
channel that modulates cardiac electrophysiology by sensing intracellular
[ATP], thus connecting the cellular energy state to membrane excitability.
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Transient forebrain or global ischemia induces delayed cell death of hippocam-
pal CA1 pyramidal neurons and impaired cognition. Potassium (Kþ) channels
are implicated as key players in ischemia-induced death. The KCNQ1Kþ chan-
nel assembles with the auxiliary subunit KCNE1 to produce the slow compo-
nent of Ik in the heart. Emerging evidence indicates that KCNQ1 mRNA and
protein are expressed not only in heart, but also brain, although its function
in neurons is, as yet, unclear.
The transcription factor REST (repressor element-1 silencing transcription fac-
tor)/NRSF (neuron-specific silencing factor) is upregulated in response to
global ischemia and contributes to neuronal death. We recently showed that
REST is enriched at the promoter of the KCNQ1 Kþ channel in postischemic
CA1, assessed by targeted ChIP-chip. Here we set out to assess a possible role
for KCNQ1 in ischemia-induced neuronal death. Global ischemia in vivo eli-
cited an increase in KCNQ1 mRNA at 24 (~1.4 fold) and 48 h (~3.5-fold;p < 0.04), as assessed by qPCR. Moreover, ischemia induced an increase in
KCNQ1 protein at 24 (~1.4 fold) and 48 h (~1.6 fold; p < 0.004), as assessed
by Western analysis. To examine KCNQ1 function in brain, we identified and
recorded Kþ currents from cultured hippocampal neurons with the specific
KCNQ1 inhibitor Chromanol 293B (IC50=62mM) and confirmed them with
a dominant-negative KCNQ1 mutant S277L which reduced the endogenous
current by ~50% (p < 0.005). Cultures exposed to oxygen-glucose deprivation
(an in vitro model of ischemia) showed a marked increase in KCNQ1 currents
at 48 h post ischemia (~28%, p< 0.03). These results document the presence of
functional KCNQ1 channels in hippocampal neurons, and their upregulation in
response to ischemia, consistent with a possible contribution to delayed neuro-
nal death of the CA1.
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Kv7.4 and Kv7.5 voltage-activated potassium channels are proposed to contrib-
ute to the maintenance of resting membrane voltage in smooth muscle cells. We
hadpreviously provided evidence thatKv7.4 andKv7.5 formpredominantly het-
eromeric channels when natively or exogenously expressed in vascular smooth
muscle cells. Endogenous Kv7 currents in smooth muscle cells are suppressed
upon activation of Gq coupled receptors. It remained to be elucidated if both
Kv7.4 and Kv7.5 respond similarly to low concentrations of vasopressin
(AVP), an agonist of theV1aGq-coupled receptor. using patch-clamp techniques,
we measured currents through human Kv7.4 and Kv7.5 channels expressed in-
dividually or together in A7r5 rat aortic smooth muscle cells and compared their
sensitivity to AVP (100 pM and 500 pM) and to the protein kinase C (PKC)
activator phorbol 12-myristate 13-acetate (PMA, 1nM). AVP (100 pM) and
PMA suppressed currents through Kv7.4, Kv7.5 and Kv7.5/7.5. Currents were
reduced with different voltage dependencies and potencies in the rank order:
Kv7.5 > Kv7.4/7.5 > Kv7.4. Both AVP and PMA increased the steepness of
Kv7.5 voltage-dependent activation and dramatically decreased Gmax. In con-
trast, AVP and PMA induced a rightward shift of the Kv7.4 activation curve
with only a slight reduction in maximal conductance (Gmax). The modulation
of Kv7.4/7.5 activation by AVP and PMA had intermediate biophysical charac-
teristics that were distinct from the modulation of either of the homomeric con-
figurations. These findings reinforce the significance of PKC-dependent
regulation of the Kv7 channels and suggest a differential regulation of Kv7.4
and Kv7.5 channel subunits by PKC-dependent phosphorylation.
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The role of KCNQ (Kv7) channels is well established in neurons, where they
play dominant roles in control of resting membrane potentials and cell excit-
ability. Recent studies have revealed expression of KCNQ channels in different
types of smooth muscle. Here we focused on airway smooth muscle (ASM),
whose membrane potential is primarily, determined by BK-type Kþ channels.
RT-PCR and immunostaining suggest that KCNQ 1, 4 and 5 are the predomi-
nant subtypes in rodent airway. To investigate the contribution of KCNQ chan-
nels in cholinergic-induced ASM contraction, we patch-clamped freshly
isolated ASM cells and isolated KCNQ current as the non-inactivating compo-
nent at the end of 2s depolarizations, with BK channels blocked with 1mM pax-
illine. The KCNQ current was enhanced by the KCNQ channel opener,
flupirtine (10mM), and abolished by XE991 (10mM). Although XE991 depolar-
ized the resting membrane potential, it did not affect that of ASM cells pre-
treated with carbachol. Similarly, XE991 did not effect carbachol-evoked
contractions, whereas flupirtine induced a significant relaxation. The flupirtine
effect is likely via opposing voltage-dependent Ca2þ influx, since no effect of
flupertine occurred in a low Kþ (1mM) bathing solution. Pre-treatment with the
muscarinic M3-receptor antagonist, fumarate (5nM), to prevent Gq/11-mediated
PIP2 hydrolysis did not reveal an effect of XE991 on contractions, suggesting
the mechanism of KCNQ inhibition in ASM is not due to PIP2 depletion. Inter-
estingly, an XE991-dependent increase in contractility was revealed in mice
with the b1 BK channel subunit knocked out, an effect enhanced by the M3 re-
ceptor antagonist. Thus, KCNQ channels may normally play a secondary role
to BK channels in control of cholinergic evoked contractions in ASM; however,
given that alteration in BK b1-subunit expression is known to occur in asthma,
KCNQ channels in ASM cells may be potential targets for therapeutic interven-
tion in respiratory disease.
